352 related articles for article (PubMed ID: 16455766)
81. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
Nakashima K; Yakabe Y
Biosci Biotechnol Biochem; 2007 Jul; 71(7):1650-6. PubMed ID: 17617726
[TBL] [Abstract][Full Text] [Related]
82. MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines.
Csibi A; Leibovitch MP; Cornille K; Tintignac LA; Leibovitch SA
J Biol Chem; 2009 Feb; 284(7):4413-21. PubMed ID: 19073596
[TBL] [Abstract][Full Text] [Related]
83. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.
Wray CJ; Sun X; Gang GI; Hasselgren PO
J Surg Res; 2002 May; 104(2):82-7. PubMed ID: 12020124
[TBL] [Abstract][Full Text] [Related]
84. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats.
Reddy SS; Shruthi K; Prabhakar YK; Sailaja G; Reddy GB
Arch Biochem Biophys; 2018 Feb; 639():16-25. PubMed ID: 29277369
[TBL] [Abstract][Full Text] [Related]
85. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
86. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle.
Clavel S; Coldefy AS; Kurkdjian E; Salles J; Margaritis I; Derijard B
Mech Ageing Dev; 2006 Oct; 127(10):794-801. PubMed ID: 16949134
[TBL] [Abstract][Full Text] [Related]
87. Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats.
Nordquist J; Höglund AS; Norman H; Tang X; Dworkin B; Larsson L
Mol Med; 2007; 13(9-10):461-70. PubMed ID: 17622304
[TBL] [Abstract][Full Text] [Related]
88. Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.
Tando T; Hirayama A; Furukawa M; Sato Y; Kobayashi T; Funayama A; Kanaji A; Hao W; Watanabe R; Morita M; Oike T; Miyamoto K; Soga T; Nomura M; Yoshimura A; Tomita M; Matsumoto M; Nakamura M; Toyama Y; Miyamoto T
J Biol Chem; 2016 Jun; 291(23):12184-94. PubMed ID: 27129272
[TBL] [Abstract][Full Text] [Related]
89. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.
Foletta VC; White LJ; Larsen AE; Léger B; Russell AP
Pflugers Arch; 2011 Mar; 461(3):325-35. PubMed ID: 21221630
[TBL] [Abstract][Full Text] [Related]
90. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
91. XIAP reduces muscle proteolysis induced by CKD.
Hu J; Du J; Zhang L; Price SR; Klein JD; Wang XH
J Am Soc Nephrol; 2010 Jul; 21(7):1174-83. PubMed ID: 20431038
[TBL] [Abstract][Full Text] [Related]
92. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo.
Fischer D; Gang G; Pritts T; Hasselgren PO
Biochem Biophys Res Commun; 2000 Apr; 270(1):215-21. PubMed ID: 10733930
[TBL] [Abstract][Full Text] [Related]
93. Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damage.
Kerksick CM; Roberts MD; Dalbo VJ; Kreider RB; Willoughby DS
Food Chem Toxicol; 2013 Nov; 61():47-52. PubMed ID: 23376779
[TBL] [Abstract][Full Text] [Related]
94. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo.
Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO
J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828
[TBL] [Abstract][Full Text] [Related]
95. Calpain activity and muscle wasting in sepsis.
Smith IJ; Lecker SH; Hasselgren PO
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E762-71. PubMed ID: 18492780
[TBL] [Abstract][Full Text] [Related]
96. Puerarin ameliorates skeletal muscle wasting and fiber type transformation in STZ-induced type 1 diabetic rats.
Yin L; Chen X; Li N; Jia W; Wang N; Hou B; Yang H; Zhang L; Qiang G; Yang X; Du G
Biomed Pharmacother; 2021 Jan; 133():110977. PubMed ID: 33249280
[TBL] [Abstract][Full Text] [Related]
97. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
[TBL] [Abstract][Full Text] [Related]
98. β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy.
Aversa Z; Alamdari N; Castillero E; Muscaritoli M; Rossi Fanelli F; Hasselgren PO
Biochem Biophys Res Commun; 2012 Jul; 423(4):739-43. PubMed ID: 22705301
[TBL] [Abstract][Full Text] [Related]
99. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy.
Liu L; Koike H; Ono T; Hayashi S; Kudo F; Kaneda A; Kagechika H; Manabe I; Nakashima T; Oishi Y
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34426497
[TBL] [Abstract][Full Text] [Related]
100. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.
Senf SM; Dodd SL; McClung JM; Judge AR
FASEB J; 2008 Nov; 22(11):3836-45. PubMed ID: 18644837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
